QDEL Summary

  1. NASDAQ
  2. >
  3. QDEL
TickerQDEL
DescriptionQUIDEL CORP
Quidel Corporation is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel's comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel's mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of families, communities and the world.
ExchangeNASDAQ
TypeStock
SectorHealthcare
Employees1,370
Next Earnings DateAugust 5th, 2021
IV59.958644%
IV Percentile29th
IV Rank25.09%
IV Skew-1.898391
IV Skew Percentile18th
IV Skew SentimentBullish
Option Volume449
Volume477,071
Price$141.25
Previous Close$142.95
52-Week High$306.724
52-Week Low$103.3113
50-Day Moving Avg.$125.10
200-Day Moving Avg.$145.70
10-Day Avg. Volume935,219
20-Day Avg. Volume796,022
30-Day Avg. Volume801,170
3-Month Avg. Volume822,000
PE6.54642
EPS$21.76
Outstanding Shares42,550,816
Market Capitalization$6,061,363,700
CurrencyUSD
UpdatedJuly 30th, 2021